Mechanistic aspects of NF-κB regulation: The emerging role of phosphorylation and proteolysis

Immunity

Volumn 3, Issue 3, 1995, Pages 263-272

  Finco, Timothy S ^a   Baldwin, Albert S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; SERINE PROTEINASE; TRANSCRIPTION FACTOR;

INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW;

ANIMAL; CYSTEINE ENDOPEPTIDASES; CYTOPLASM; HUMAN; MULTIENZYME COMPLEXES; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; SERINE PROTEINASE INHIBITORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028972845     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/1074-7613(95)90112-4     Document Type: Review

References (101)

1. In vivo stimulation of IKB phosphorylation is not sufficient to activate NF-KB
2. Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-KB
3. Activation of DNA binding activity in an apparently cytoplasmic precursor of the NFKB transcription factor
4. IκB: a specific inhibitor of the NFκB transcription factor
5. A 65-kD subunit of active NF-κB is required for inhibition of NF-κB by lκB
6. Function and activation of NF-κB in the immune system
7. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors
8. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention
9. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of lκBα: a mechanism for NF-KB activation
10. Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs
11. A novel mitogeninducible gene product related to p50/p105-NF-κB participates in transactivation through a κB site
12. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers
13. Coupling of a signal response domain in lκBα to multiple pathways for NF-κB activation
14. Mutual regulation of the transcription factor NF-κB and its inhibitor IκBa
15. Control of IκB-a proteolysis by site-specific, signal-induced phosphorylation
16. Transcriptional induction of the murine c-rel gene with serum and phorbol-12-myristate-13-acetate in fibroblasts
17. Expression of ReIB is required for the development of thymic medulla and dendritic cells
18. Signal-induced site-specific phosphorylation targets IKBa to the ubiquitin-proteasome pathway
19. Autoregulation of IκBα activity
20. The ubiquitin-proteasome proteolytis pathway
21. Promoter of the human NF-κB p50/p105 gene: regulation by NF-κB subunits and by c-Rel
22. IκBα can localize in the nucleus but shows no direct transactivation potential
23. Physiologic turnover of nuclear factor κB by nuclear proteolysis
24. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1 cells
25. Cytokine-inducible expression in endothelial cells of an IκBa-like gene is regulated by NF-κB
26. Phosphorylation of lκBα precedes but is not sufficient for its dissociation from NF-κB
27. Tumornecrosis factor-α-dependent activation of a ReIA homodimer in astrocytes
28. Proteolytic processing of NF-κB/IκB in human monocytes
29. rel is rapidly tyrosine-phosphorylated following granulocyte-colony stimulating factor treatment of human metrophils
30. Inducible phosphorylation of IκBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors
31. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers
32. IκB/MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding
33. cactus, a gene involved in dorsoventral pattern formation of Drosophila, is related to the IκB gene family of vertebrates
34. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB
35. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal
36. Structure of NF-κB p50 homodimer bound to a κB site
37. The IκB proteins: members of a multifunctional family
38. Structure and autoregulation of the c-rel promoter
39. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity
40. The ankyrin repeat domains of NF-κB precursor pl05 and the protooncogene bcl-3 act as specific inhibitors of NF-κB DNA binding
41. Common structural constituents confer IκB activity to NF-κB p105 and IκB/ Mad-3
42. Identification of a new serine kinase that activates NF-κB by direct phosphorylation
43. Rapid proteolysis of IκB-α in response to phorbol ester, cytokines and lipopolysaccaride is a necessary step in the activation of NF-κB
44. Maintenance of NF-κ8 activity is dependent on protein synthesis and the continuous presence of external stimuli
45. Direct association of pp40/IκB-b with rel/NF-κB transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity
46. Molecular genetics of Drosophila immunity
47. Dif, a dorsal-related gene that mediates an immune response in Drosophilia
48. Three NF-κB sites in the IKBa promoter are required for induction of gene expression by TNFa
49. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-κB) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro
50. Characterization of the Drosophilia cactus locus and analysis of interactions between cactus and dorsal proteins
51. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product
52. The c-rel protooncogene is essential for lymphocyte proliferation and interleukin-2 expression
53. Promoter analysis of the gene encoding the IκBα/MAD3 inhibitor of NF-κB: positive regulation by members of the rel/NF-κ8 family
54. NF-κB/Rel family members are physically associated phosphoproteins
55. Phosphorylation of NF-κB1-p50 is involved in NF-κ8 activation and stable DNA binding
56. Activation of NF-κB requires proteolysis of the inhibitor IκBa: signal-induced phosphorylation of lκBα alone does not release active NF-κB
57. Sequential induction of NF-κB/Rel family proteins during B-cell terminal differentiation
58. Transcriptional regulation of NF-κB2: evidence for κB-mediated positive and negative autoregulation
59. Sphingomyelinase activates proteolytic IκBa degradation in a cell-free system
60. Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers
61. Proteolytic degradation of MAD3 (IκBa) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κ8
62. Molecular cloning and characterization of a novel ReI/NF-κB family member displaying structural and functional homology to NF-κB p50/p105
63. Cloning of the DNA-binding subunit of human nuclear factor κB: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor α
64. Enhanced IκBa degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines
65. Tumor necrosis factor a-induced phosphorylation of IκBa is a signal for its degradation but not dissociation from NF-κB
66. Structure of the NF-κB p50 homodimer bound to DNA
67. An inducible transcription factor activates expression of human immunodeficiency virus in T cells
68. Activation of NF-κB in vivo is regulated by multiple phosphorylations
69. The NF-κB precursor p105 and the proto-oncogene product Bcl-3 are IκB molecules and control nuclear translocation of NF-κB
70. Identification of complex formation between two intracellular tyrosine kinase substrates; human c-Rel and the p105 precursor of p50 NF-κB
71. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide
72. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB
73. In vivo control of NF-κB activation by IκBa
74. The precursor of NF-κB p50 has IκBα like functions
75. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
76. Inducible degradation of IκBa in vitro and in vivo requires the acidic C-terminal domain of the protein
77. A gradient of nuclear localization of the dorsal protein determines dorsoventral pattern in the Drosophila embryo
78. Isolation of a rel-related human cDNA that potentially encodes the 65 kD subunit of NF-κB
79. The graded distribution of the dorsal morphogen is initiated by selective nuclear transport in Drosophila
80. ReIB, a new Rel family transcription activator that can interact with p50 NF-κB
81. NF-κB p1 00 (Lyt-10) is a component of H2TF1 and can function as an IκB-like molecule
82. Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65
83. The p65 subunit of NF-κB regulates IκB by two distinct mechanisms
84. Inducibility of κ immunoglobulin enhancer-binding protein NF-κ8 by a posttranslational mechanism
85. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
86. In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C
87. Structure, regulation and function of NF-κB
88. Relocalization of the dorsal protein from the cytoplasm to the nucleus correlates with its function
89. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway
90. Autoregulation of the NF-κB transactivator ReIA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs
91. Human T-cell leukemia virus type I tax activation of NF-κB/Rel involves phosphorylation and degradation of IκBa and ReIA (p65)mediated induction of the c-rel gene
92. The characterization of the promoter of the gene encoding the p50 subunit of NF-κB indicates that it participates in its own regulation
93. NF-κB: a lesson in family values
94. Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex
95. IκBβ regulates the persistent response in a biphasic activation of NF-κB
96. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of lκBα that is still bound to NF-κB
97. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli
98. The NF-κB p65 promoter
99. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family
100. Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA
101. Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus